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Objective. To delineate the clinical behaviour of chronic benign neutropenia in
Chinese children in Hong Kong.
Design. Retrospective study.
Setting. University teaching hospital, Hong Kong.
Patients. All infants and children with absolute neutrophil count of 1.5 x 109 /L
or lower for more than 3 months.
Main outcome measures. Development of significant infection, and achieve-
ment of remission.
Results. Twenty-four children with chronic benign neutropenia were identified
between 1992 and 2001. Their median age of diagnosis was 9 months. The
mean (standard deviation) initial absolute neutrophil count was 0.28 x 109 /L
(0.24 x 109 /L). Twenty-three patients presented with infection. Of the 19
patients tested, four (21%) were positive for anti-neutrophil antibodies. Bone
marrow examination was performed in 17 patients: nine had normal results, but
six showed evidence of peripheral consumption, one showed late maturation
arrest at band stage, and one showed phagocytosis of myeloid cells by histiocytes.
The overall hospitalised infection rate was 51.6 episodes per 1000 patient-
months. Ten percent of cases were considered ‘significant’ infections and
required hospital admission with either surgical intervention or intravenous
therapy (antibiotics or fluid replacement). In the first year of diagnosis, more
than 80% of patients had their lowest absolute neutrophil count (mean,
0.16 x 109 /L; standard deviation, 0.11 x 109 /L). Granulocyte-colony stimulating
factor was used to treat three patients and induced transient elevation of
absolute neutrophil count in all three. The projected remission rate was 55.4%
at 3 years. Even for those with persistent disease, there was significant recovery
in absolute neutrophil count to a mean of 0.5 x 109 /L (P<0.01).
Conclusions.  Patients with chronic benign neutropenia experienced a relatively
benign clinical course regardless of their remission status. Only a small propor-
tion of patients developed significant infections. A multi-centre prospective
study may help identify predictive factors of remission.
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Introduction
Chronic benign neutropenia (CBN) of infancy and child-
hood was first described by Hotz and Fanconi in 1941 as
described by Dale.1 Subsequently, Zuelzer and Bajoghli2
defined it as “a chronic state of mature neutrophil depletion
with a compensatory increase in the immature granulocytes
in the bone marrow analogous to erythroid hyperplasia in
haemolytic anaemia”. The condition actually encompasses
two groups of disorder—namely, autoimmune neutropenia
(AIN) and chronic idiopathic neutropenia (CIN). So far, there
has been no universally agreed nomenclature and classifi-
cation for chronic neutropenia in children.
Autoimmune neutropenia is defined as the presence
of anti-neutrophil antibodies. Its incidence is approximately
1 in 100 000 children.3 The largest series (240 patients
with AIN) was reported by Bux et al4: the typical age at
diagnosis among the patients was 5 to 15 months, and the
majority (>90%) of patients had only benign infections,
despite the severe neutropenia. Spontaneous remission was
observed within 24 months; symptomatic treatment with
antibiotics was sufficient in most cases, and granulocyte-
colony stimulating factor (G-CSF) was indicated only
under special circumstances. Similar observations have
been made by Lalezari et al5 in a series of 119 infants and
children with AIN. Chronic idiopathic neutropenia shares
a similar clinical course with AIN, differing only in the
absence of anti-neutrophil antibodies.1 In fact, because
tests designed to detect antibodies to neutrophils can be non-
specific and often unavailable, differentiation between CIN
and AIN can be difficult.6
In this study, we reviewed our experience on CBN
(ie AIN and CIN) among infants, and attempted to de-
lineate its clinical course among local Chinese children.
Methods
A retrospective review of all Chinese patients who received
a diagnosis of chronic neutropenia between 1992 and 2001
was performed in the Department of Paediatrics and
Adolescent Medicine of the Queen Mary Hospital. Chronic
neutropenia was defined as having an absolute neutrophil
count (ANC) of 1.5 x 109 /L or lower for at least 3 months.
For patients who presented with neutropenia for more than
3 months, initial investigations included determination of
the complete blood picture twice a week for 4 weeks, im-
munoglobulin profiling, measurement of the level of anti-
neutrophil antibodies, and bone marrow examination.
Patients were followed up monthly in the initial 6 months
to reach a definitive diagnosis. They were subsequently
reviewed regularly at 6- to 9-month intervals through
clinical assessment and determination of the complete blood
picture. Additionally, the patients and their parents were
instructed to return to the out-patient clinic or emergency
room of our hospital for assessment when they had a fever
or other symptoms suggestive of infection.
Records of patients with chronic neutropenia diagnosed
during the 10-year study period were retrieved. We excluded
all patients with congenital neutropenia, cyclic neutropenia,
neutropenia ‘secondary’ to allo-immunity, or other immune
or systemic diseases, because the aetiologies, clinical
manifestations, natural courses, and prognoses of these
disease entities were different from those of CBN.6-9
In general, the categorisation of chronic neutropenia
was based on the time of onset, the pattern of variation in
neutrophil levels in the blood, and the presence or absence
of auto-antibodies. We followed the diagnostic criteria
suggested by Dale et al6 for congenital neutropenia, cyclic
neutropenia, and CIN, and criteria suggested by Bux
et al4 for AIN. Congenital neutropenia was usually rec-
ognised from birth by the presence of severe infection,
severe neutropenia (ANC of <0.5 x 109 /L), and bone
marrow showing a maturation arrest of neutrophil produc-
tion at an early stage. Cyclic neutropenia was generally
presumed to be present if there were oscillations of blood
neutrophil count in a cycle of 21 days and if patients were
prone to develop severe infections during periods of severe
neutropenia. Although no operational definition could be
found for virus-induced neutropenia, none of the patients
showed any clinical evidence suggestive of an obvious
viral cause (eg viral hepatitis). Autoimmune neutropenia was
defined as neutropenia in the presence of anti-neutrophil
antibody, as detected by an assay described previously by
Rose et al.10 The limitation of the assay was that its speci-
ficity was unknown. Chronic idiopathic neutropenia was a
diagnosis by exclusion and was defined as chronic neutro-
penia of unknown origin with which no other pathology
could be associated.11
A total of 24 patients were identified during the
study period. The total observation time was 1356 patient-
months up to the time of chart review, and the median
follow-up duration per patient was 56.5 months (range,
8.0-118.0 months). The clinical features, serial neutrophil
counts, results of other investigations, and the use of G-CSF
were examined. Granulocyte-colony stimulating factor
has been shown to be useful in inducing temporary remis-
sion of neutropenia.4 Furthermore, long-term safety of G-
CSF has been shown in patients with severe congenital
neutropenia, and in early 1990s, it was used for diagnostic
challenge for chronic neutropenia—patients suspected to
have chronic neutropenia were ‘challenged’ with doses of
G-CSF and observed for elevation in ANC to confirm the
diagnosis.6 Nowadays, the administration of G-CSF has been
restricted to short-term treatment in patients with CBN—
either for severe infections or before surgical intervention.4
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Each episode of infection that required hospitalisation
was also reviewed. ‘Significant’ infection was defined
arbitrarily as infection requiring hospital admission plus
either surgical intervention or intravenous therapy
(intravenous antibiotics or intravenous fluid replacement).
Remission was defined as persistent normalisation of
the neutrophil count (≥1.5 x 109 /L) for more than 3 months.
The projected remission rate at a certain interval was
calculated as the cumulative incidence of recovery.
Univariate analysis was used to determine potential
factors affecting remission, including the age of onset,
presenting features, initial neutrophil count, lowest
neutrophil count, bone marrow findings, anti-neutrophil
antibody test results, number of hospitalised infections
in the first year after diagnosis, and total number of
hospitalised infections. Multivariate logistic regression
was also performed with these factors as independent
variables. A cut-off P value of ≤0.05 was taken as
statistically significant.
Results
The median age at presentation was 9.0 months (range,
1.5-66.0 months), and the male-to-female ratio was 1:1. The
presenting features are summarised in Table 1. The major-
ity of patients presented with various forms of infection,
whereas one patient was discovered incidentally after
surgery for ventricular septal defect. No patient had a
family history for chronic neutropenia during infancy.
The mean (standard deviation [SD]) ANC on presenta-
tion was 0.28 x 109 /L (0.24 x 109 /L) and the median
ANC was 0.23 x 109 /L (range, 0-0.49 x 109 /L). Of the 19
patients who were tested for anti-neutrophil antibodies,
four (21%) had positive results and were classified as
having AIN; the majority (15 patients, 79%) were thus clas-
sified as having CIN. As associated findings, monocytosis
and thrombocytosis were relatively common; they affected
25% and 40% of patients, respectively. Immunoglobulin
profiles were obtained for 18 patients and were generally
similar to the age- and sex-matched immunoglobulin levels
of local Hong Kong Chinese children.12 Twelve patients
had normal profiles, two had an increased level of one im-
munoglobulin (IgA [n=1]; IgG [n=1]), three had increased
levels of two immunoglobulins (both IgA and IgG [n=2];
both IgG and IgM [n=1]), and one patient had increased
levels of all three immunoglobulins.
Bone marrow examination had been performed in
17 (71%) patients. Results of nine (53%) patients were
normal, whereas six (35%) showed evidence of increased
granulopoiesis, which suggested peripheral consumption.
One of the two remaining patients showed late-maturation
arrest at band stage; the other showed prominent histiocytes
* A: autoimmune neutropenia; C: chronic idiopathic neutropenia
† ANC absolute neutrophil count
‡ PD: persistent disease; SR: spontaneous remission
§ URTI upper respiratory tract infection
Table 1. Chronic benign neutropenia of infancy and childhood in Hong Kong Chinese patients
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and phagocytosis of myeloid cells. These findings have all
been reported in a previous series4 and were compatible
with the diagnosis of CBN. Marrow examination had not
been performed in seven (29%) patients, either because of
parental refusal or because the clinician decided to use a
‘wait and see’ approach.
There were a total of 70 episodes of infection that
required hospitalisation (Table 2), corresponding to a rate
of 51.6 per 1000 patient-months. More than 70% of these
infection episodes were cases of upper respiratory tract
infection (URTI) and childhood exanthema. The remaining
17 infection episodes were skin and soft-tissue infections
(14%), lower respiratory tract infections (5%), and gastro-
enteritis (6%). Of these 17 episodes, nine had pathogens
identified and all were bacteria. Of all 70 infection episodes,
seven were by definition ‘significant’ (Table 2) and required
either surgery or some form of intravenous therapy.
During these significant infections, the mean ANC was
0.20 x 109 /L (range, 0.09-0.40 x 109 /L). All other cases ran
a benign course and did not require treatment beyond
symptomatic management or oral antibiotics. Only the
four cases of soft-tissue abscess required surgical inter-
vention in the form of incision and drainage. In all,
G-CSF was given to only three patients: for diagnostic
challenge in two, and to increase the neutrophil count
before incision and drainage in the third patient, who had a
right thigh abscess complicated by erythema gangrenosum.
Although the neutrophil count increased transiently in
all three cases, it did not last longer than 7 days. A recur-
rent chest infection was observed in a patient who had a
concomitant sequestrated lung. Recurrence of significant
infections was not seen in other patients. Eighty-eight
percent of all significant infections and 63% of all
hospitalised infections occurred within the first year of
diagnosis.
During the follow-up period, the mean (SD) of the
lowest recorded ANC was 0.16 x 109 /L (0.11 x 109 /L)
and median was 0.10 x 109 /L (range, 0-0.49 x 109 /L).
For 12 (50%) of the patients, the ANC was lowest at
presentation, and for 20 (83%), it was within the first
year of diagnosis. Thirteen patients had persistent disease
until the last follow-up visit, when the mean (SD) ANC was
0.5 x 109 /L (0.4 x 109 /L) and median was 0.42 x 109 /L
(range, 0.1-1.34 x 109 /L). There was a significant increase
in the mean ANC when comparing the lowest value with
the ANC value at the last follow-up (P<0.01).
Eleven (46%) children eventually achieved remission.
The estimated remission rate at 3 years was 55.4% (Fig).
After 3 years of follow-up, the rate of remission seemed
to reach a plateau, and no new cases of remission were
detected. All the remissions were spontaneous and were
not related to the use of G-CSF. There was no documented
relapse after remission. Univariate analysis and multivariate
%
Follow-up duration (months)
0
0
n=24   55.41%
20 40 60 80
20
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Fig . Probability of achieving remission in chronic benign
neutropenia of infancy
* Granulocyte-colony stimulating factor was used in the patient with thigh abscess, and in two other patients for diagnostic challenge
Table 2. Location and frequency of hospitalised infections in 24 patients with chronic benign neutropenia
noitacoL )%(.oN niderruccO
raeytsrifeht
retfa
sisongaid
)%(.oN
suonevartnideriuqeR
ypareht
lacigrusderiuqeR
noitnevretni
snegohtaP
doohdlihC
amehtnaxe
yrotaripserreppU
,raednatcart
taorhtdna,eson
snoitcefni
yrotaripserrewoL
noitcefnitcart
sitiretne-ortsaG
dnanikS
eussitevitcennoc
dnanoitcefni
sessecsba
latoT
)41(01 1
)16(34 1
1 )5(3 11
1 )6(4 11
)41(01 1
)001(07
1 )01(7
)13(22
1 )5(3 1
1 )3(2 1
)41(01
)36(44
0
0
suonevartni(2
)scitoibitna
diulfsuonevartni(1
)tnemecalper
suonevartni(4
4ehtrofscitoibitna
)sesaclacigrus
7
0
0
0
0
ralubidnambustfel(4
hgihtthgir,ssecsba
laretalib,ssecsba
dnassecsbalavluv
)ssecsbaplacs
4
,dnah1;xopnekcihc4;aloesor4
reveftelracs1;esaesidhtuomdnatoof
srehto;surivoneda1;azneulfniarap3
detnemucod/deifitnediton
2 asonigureasanomoduesP srehto;
deifitnediton
1 ilocaihcirehcsE deifitneditonsrehto;
yregrusderiuqersesac4
1( sueruasuccocolyhpatS ,
1 asonigureasanomoduesP dexim1,
fosesac3;)deifitnediton1,htworg
evitisnes-nillicihtem succocolyhpatS
suerua deifitneditonsesac3;
-
*
Hong Kong Med J Vol 10 No 4 August 2004     235
Chronic neutropenia in Chinese children
logistic regression both showed that the likelihood of
remission was not associated with any of the following
factors: age of presentation (P=0.423), presence of
anti-neutrophil antibody (P=0.577), initial ANC (P=0.611),
lowest ANC (P=0.537), normal bone marrow (P=0.27),
total number of hospitalised infections (P=0.639), and the
number of hospitalised infections in the first year after
diagnosis (P=0.706).
Discussion
We report on a cohort of 24 Chinese patients with
paediatric CBN during a 10-year period. Although cyclic
and congenital neutropenia were excluded conditions,
actually no cases were identified from our clinic database.
Yet, the cohort in the series of Hong Kong children de-
scribed by Leung et al13 was more heterogeneous and
consisted of five patients with congenital neutropenia,
six with cyclic neutropenia, two with AIN, and five
with idiopathic neutropenia. We cannot explain this
heterogeneity, because details of the diagnostic criteria
cannot be found in their article. Still, among their series,
two of the five patients with congenital neutropenia and
four of their six patients with cyclic neutropenia had
spontaneous remission. The incidence and spectrum of
infections were also not described, and thus limited the
comparison of the propensity for infection with that in
our study.
Patients in western series of Bux et al4 and Lalezari
et al5 and those in our study shared similar clinical charac-
teristics—namely, the age of onset (9, 8, and 9 months,
respectively), male-to-female ratio (1:1, 4.6:5.4, and 4:6,
respectively), and associated monocytosis. In our study,
increased immunoglobulin level was found in 6 (25%)
of the 24 patients. This finding has also been reported
previously and was postulated to be due to chronic immune
stimulation.14 No patients in our series had a decreased level
of immunoglobulin, which was suggestive of humoral
immunodeficiency. The positivity rate for anti-neutrophil
antibodies was low in our series. This finding could be partly
because repeating anti-neutrophil antibody studies was
not a routine practice in our unit in the earlier years of the
study period. Patients were not retested, despite testing
negative during initial investigations, because a previous
study,1 as well as our own experience, suggested that AIN
and CIN were similar in clinical course and prognosis,
irrespective of the presence of anti-neutrophil antibody. In
our cohort of 24 patients, only one has been tested twice
for anti-neutrophil antibody and results on both occasions
were negative. Bux et al4 found it was sometimes necessary
to repeat studies up to 3 times before antibodies could be
detected.
The hospitalised infection rate in our study was 51.6
events per 1000 patient-months, which corresponded to
0.62 hospitalised events per patient-year. More than 70%
of the infections were URTI or childhood exanthema in
which no pathogens could be identified. In addition, the
hospitalisation rate for URTI was 31.4 per 1000 patient-
months among the patients; half of the events occurred in
the first year of diagnosis. Local data on the hospitalisation
rate for URTI in children was not available, but given the
fact that a normal healthy child could have up to eight URTIs
per year,15 these figures might reflect merely the ‘back-
ground’ infections occurring even in the healthy paediatric
population. Furthermore, URTIs in children are commonly
viral in origin, and their occurrence is probably unrelated
to neutropenia, which predisposes to bacterial infection.16
The relatively high admission rate for URTI in the first year
after diagnosis could be explained by the younger age at
diagnosis, which made the patients more prone to develop
infections. Moreover, the ‘cautiousness’ of parents having
a child who had recently received a diagnosis of CBN no
doubt led them to seek medical attention whenever their
children developed a fever. On the other hand, six of the
seven cases we considered as ‘significant’ were positive for
bacterial culture (two cases of Pseudomonas pneumonia,
one case of Escherichia coli gastro-enteritis, and three
cases of soft-tissue and skin abscesses), and it seems that
they were more representative of cases related to chronic
neutropenia. All seven cases occurred within first year of
diagnosis. None of the infections had any major long-term
consequences. Recurrent cases had associated risk factors
(eg anatomical defects such as sequestrated lung). These
findings demonstrated the benign nature of the disease.
Furthermore, all patients remained stable after the first year
of diagnosis regardless of their ANC and remission status.
The projected remission rate was 55.4% at 3 years, with
a mean duration of neutropenia of 28.6 months. The mean
duration of disease was 20 months in the cohort of Lalezari
et al5 and 7-25 months in that of Bux et al4; more than 90%
of patients in these two series displayed spontaneous
remission. Patients in our study seem to have a lower
remission rate than that reported. This difference could
be because of our stringent criteria of remission (ANC of
>1.5 x 109 /L). If an ANC of at least 1.0 x 109 /L was taken
as our remission criteria, there would have been four more
cases of remission, giving us a remission rate of 77.8% at
3 years. It would be interesting to follow up the patients
with persistent disease to see whether remission could be
achieved later. However, even for these patients, the ANC
increased from the lowest median value of 0.10 x 109 /L to
0.42 x 109 /L at the most recent follow-up visit. We could
not identify prognostic factors in predicting remission in
chronic neutropenia of infancy. Similarly, no independent
prognostic factors could be identified in the study of Leung
et al13 from multiple logistic regression analysis. Our small
sample probably did not have the statistical power to draw
any definite conclusion.
In summary, patients with CBN experienced a relatively
benign clinical course regardless of their remission status.
However, thorough investigation and repeated assessment
would be essential to exclude other causes of neutropenia
Chung et al
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that have more serious complications—for example,
Kostmann syndrome and other forms of congenital
neutropenia. A multi-centre prospective study may help
identify predictive factors of remission.
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